March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering ... reflecting our ongoing focus on working capital management and the benefits from our 2024 ...

NEWTOWN, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations at Nevro Corp. (“Nevro”).